VOV.VN - Vietnam is hopeful it can produce its first local COVID-19 vaccine this year, with the third trial phase of trials for the NanoCovax vaccine set to be completed in late September while the COVIVAC vaccine will enter the second phase by the end of June, according to the Ministry of Health (MoH).

VOV.VN - Nanogen Pharmaceutical Biotechnology JSC have announced plans to launch the third phase of human trials for its locally-produced coronavirus vaccine Nano Covax on May 5, a timeframe which is three months ahead of schedule.

As many as 554 volunteers joining the second-stage human trials of home-grown Nano Covax COVID-19 vaccine got the second shots over the past 14 days.

The National Regulatory Authority (NRA) of Vietnam moves one level in the World Health Organization (WHO)’s rating scale for the safety and efficacy of vaccines.

VOV.VN - A further 36 volunteers participating in human trials for Covivac, the second locally-produced COVID-19 vaccine, have been given the first shot, according to Vu Dinh Thiem, director of the Center for Clinical Trials under the National Institute of Hygiene and Epidemiology.

VOV.VN - A total of 367 volunteers, including 30 people over the age of 60, have been injected with Nano Covax, the nation’s first locally-produced novel coronavirus (COVID-19) vaccine as part of the second phase of human trials, according to the Military Medical University.

VOV.VN - The Ministry of Health confirmed no new locally-transmitted COVID-19 cases on the morning of March 1, keeping the national tally at 2,448, while the total recoveries hit 1,876 in total after a further 32 coronavirus patients were declared free from the virus one day earlier.

VOV.VN - The second phase of trial injections for Nano Covax, the locally-produced COVID-19 vaccine, will be conducted on over 560 volunteers aged between 18 and 65, with the first trial shot being carried out on February 26, according to Nguyen Ngo Quang, deputy head of the Department of Science-Technology and Training.

VOV.VN - The country will get approximately five million doses of the novel coronavirus (COVID-19) vaccine by the end of February, including some 4.9 million vaccine doses provided via Covax, a global mechanism for developing, manufacturing, and procuring the COVID-19 vaccine.

The National Steering Committee for COVID-19 Prevention and Control has ordered the tightening of border control to prevent any illegal entry.